Affiliations: [a] Department of Neuroradiology, Lariboisière University Hospital, Paris, France | [b]
Grenoble Alps University Hospital, IRMaGe, Grenoble, France | [c] Centre d’Explorations Fonctionnelles Otoneurologiques, Paris, France
| [d] Department of Head and Neck Surgery, Lariboisière University Hospital, Paris, France
Correspondence:
[*]
Corresponding author: Michael Eliezer Neuroradiology Unit, Lariboisière University Hospital, 75010 Paris, France. Tel.: +33 7 81 51 13 16; Fax: +33 1 49 95 83 63; E-mail: michael.eliezer@aphp.fr.
Abstract: BACKGROUND:Since the first description by Hallpike and Cairns, the excess of endolymphatic fluid, also known as endolymphatic hydrops (EH), has been established as being the main biomarker in patients with Menière’s disease. Recently, the concept of primary (PHED) and secondary hydropic ear disease (SHED) has been introduced. PHED corresponded to Menière’s disease while SHED was defined as the presence of EH in patients with pre-existing inner ear disease. OBJECTIVE:In this article, we would like to summarize the methodology of hydrops exploration using MRI and the previously published radiological findings in patients with PHED and SHED. RESULTS:Before the emergence of delayed inner ear MRI, the presence of EH was assumed based on clinical symptoms. However, because of the recent technical developments, inner ear MRI became an important tool in clinical settings for identifying EH in vivo, in patients with PHED and SHED. The presence of EH on MRI is related with the degree of sensorineural hearing loss whether in patients with PHED or SHED. By contrast, in PHED or SHED patients without sensorineural hearing loss, MRI showed no sign of EH. CONCLUSIONS:Thanks to the recent technical developments, inner ear MRI became an important tool in clinical settings for identifying EH in vivo, in patients with PHED and SHED.
